Luye Pharma Group Ltd. ( LYPHF) - Stock Earnings
LYPHF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 43.7 million USD | 444.0 million USD |
| 2025Q4 | 43.0 million USD | 439.6 million USD |
| 2026Q2 | 56.7 million USD | 435.8 million USD |
LYPHF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 75.2 million USD | 867.8 million USD |
| 2024 | 64.6 million USD | 830.4 million USD |
| 2025 | 86.2 million USD | 878.4 million USD |
| 2026 Est. | — | — |
LYPHF
Price: $0.27
52 week price:
Earnings Per Share: 0.01 USD
P/E Ratio: 27
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.1 billion